nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.284	1	CpDpCtD
Ropinirole—ADRA2A—type 2 diabetes mellitus	0.0779	0.325	CbGaD
Ropinirole—HTR2C—type 2 diabetes mellitus	0.0717	0.299	CbGaD
Ropinirole—CYP1A2—type 2 diabetes mellitus	0.0541	0.226	CbGaD
Ropinirole—CYP3A4—type 2 diabetes mellitus	0.0358	0.15	CbGaD
Ropinirole—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0316	0.107	CbGbCtD
Ropinirole—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0225	0.0762	CbGbCtD
Ropinirole—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0186	0.0627	CbGbCtD
Ropinirole—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0182	0.0614	CbGbCtD
Ropinirole—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0178	0.0602	CbGbCtD
Ropinirole—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0168	0.0567	CbGbCtD
Ropinirole—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0161	0.0546	CbGbCtD
Ropinirole—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0161	0.0546	CbGbCtD
Ropinirole—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0153	0.0518	CbGbCtD
Ropinirole—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0118	0.04	CbGbCtD
Ropinirole—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0111	0.0377	CbGbCtD
Ropinirole—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0107	0.036	CbGbCtD
Ropinirole—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0107	0.036	CbGbCtD
Ropinirole—DRD2—Bromocriptine—type 2 diabetes mellitus	0.00981	0.0332	CbGbCtD
Ropinirole—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00578	0.0195	CbGbCtD
Ropinirole—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00516	0.0174	CbGbCtD
Ropinirole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00509	0.0172	CbGbCtD
Ropinirole—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00476	0.0161	CbGbCtD
Ropinirole—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00455	0.0154	CbGbCtD
Ropinirole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00454	0.0153	CbGbCtD
Ropinirole—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0043	0.0145	CbGbCtD
Ropinirole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00415	0.014	CbGbCtD
Ropinirole—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00391	0.0132	CbGbCtD
Ropinirole—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00375	0.0127	CbGbCtD
Ropinirole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00363	0.0123	CbGbCtD
Ropinirole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00328	0.0111	CbGbCtD
Ropinirole—CYP1A2—Losartan—type 2 diabetes mellitus	0.00293	0.00991	CbGbCtD
Ropinirole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00249	0.00841	CbGbCtD
Ropinirole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00238	0.00806	CbGbCtD
Ropinirole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00238	0.00806	CbGbCtD
Ropinirole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00225	0.00762	CbGbCtD
Ropinirole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00168	0.00568	CbGbCtD
Ropinirole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00154	0.00519	CbGbCtD
Ropinirole—HTR2A—arteriole—type 2 diabetes mellitus	0.00135	0.114	CbGeAlD
Ropinirole—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.000863	0.0725	CbGeAlD
Ropinirole—DRD1—nerve—type 2 diabetes mellitus	0.000837	0.0703	CbGeAlD
Ropinirole—HTR1B—artery—type 2 diabetes mellitus	0.000684	0.0575	CbGeAlD
Ropinirole—HTR1D—artery—type 2 diabetes mellitus	0.000662	0.0556	CbGeAlD
Ropinirole—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00058	0.0487	CbGeAlD
Ropinirole—HTR2A—hindlimb—type 2 diabetes mellitus	0.000537	0.0451	CbGeAlD
Ropinirole—DRD2—nerve—type 2 diabetes mellitus	0.000495	0.0416	CbGeAlD
Ropinirole—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000492	0.0414	CbGeAlD
Ropinirole—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000418	0.0352	CbGeAlD
Ropinirole—HTR2A—artery—type 2 diabetes mellitus	0.000329	0.0276	CbGeAlD
Ropinirole—HTR2A—nerve—type 2 diabetes mellitus	0.000326	0.0274	CbGeAlD
Ropinirole—HTR2A—endothelium—type 2 diabetes mellitus	0.000278	0.0233	CbGeAlD
Ropinirole—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000238	0.02	CbGeAlD
Ropinirole—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.00023	0.0193	CbGeAlD
Ropinirole—HTR1D—kidney—type 2 diabetes mellitus	0.000225	0.0189	CbGeAlD
Ropinirole—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000214	0.018	CbGeAlD
Ropinirole—DRD2—retina—type 2 diabetes mellitus	0.000205	0.0172	CbGeAlD
Ropinirole—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000204	0.0171	CbGeAlD
Ropinirole—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000192	0.0161	CbGeAlD
Ropinirole—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000189	0.0159	CbGeAlD
Ropinirole—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000188	0.0158	CbGeAlD
Ropinirole—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000186	0.0156	CbGeAlD
Ropinirole—ADRA2C—kidney—type 2 diabetes mellitus	0.000165	0.0138	CbGeAlD
Ropinirole—ADRA2C—pancreas—type 2 diabetes mellitus	0.000164	0.0138	CbGeAlD
Ropinirole—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000161	0.0135	CbGeAlD
Ropinirole—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000149	0.0125	CbGeAlD
Ropinirole—HTR2A—retina—type 2 diabetes mellitus	0.000135	0.0114	CbGeAlD
Ropinirole—ADRA2A—pancreas—type 2 diabetes mellitus	0.000131	0.011	CbGeAlD
Ropinirole—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000128	0.0108	CbGeAlD
Ropinirole—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000119	0.00996	CbGeAlD
Ropinirole—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000114	0.0096	CbGeAlD
Ropinirole—HTR2A—kidney—type 2 diabetes mellitus	0.000112	0.0094	CbGeAlD
Ropinirole—ADRA2C—liver—type 2 diabetes mellitus	0.000104	0.00875	CbGeAlD
Ropinirole—CYP3A4—kidney—type 2 diabetes mellitus	0.000104	0.0087	CbGeAlD
Ropinirole—CYP2D6—kidney—type 2 diabetes mellitus	0.000102	0.00856	CbGeAlD
Ropinirole—CYP1A2—liver—type 2 diabetes mellitus	9.04e-05	0.0076	CbGeAlD
Ropinirole—HTR2A—liver—type 2 diabetes mellitus	7.07e-05	0.00594	CbGeAlD
Ropinirole—CYP3A4—liver—type 2 diabetes mellitus	6.54e-05	0.0055	CbGeAlD
Ropinirole—CYP2D6—liver—type 2 diabetes mellitus	6.44e-05	0.00541	CbGeAlD
Ropinirole—Anxiety—Irbesartan—type 2 diabetes mellitus	2.17e-05	0.000192	CcSEcCtD
Ropinirole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	2.17e-05	0.000192	CcSEcCtD
Ropinirole—Nervous system disorder—Metformin—type 2 diabetes mellitus	2.17e-05	0.000192	CcSEcCtD
Ropinirole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	2.17e-05	0.000191	CcSEcCtD
Ropinirole—Dyspnoea—Valsartan—type 2 diabetes mellitus	2.17e-05	0.000191	CcSEcCtD
Ropinirole—Vertigo—Losartan—type 2 diabetes mellitus	2.16e-05	0.000191	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	2.16e-05	0.000191	CcSEcCtD
Ropinirole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	2.16e-05	0.000191	CcSEcCtD
Ropinirole—Somnolence—Valsartan—type 2 diabetes mellitus	2.16e-05	0.000191	CcSEcCtD
Ropinirole—Syncope—Losartan—type 2 diabetes mellitus	2.16e-05	0.000191	CcSEcCtD
Ropinirole—Paraesthesia—Orlistat—type 2 diabetes mellitus	2.16e-05	0.000191	CcSEcCtD
Ropinirole—Leukopenia—Losartan—type 2 diabetes mellitus	2.16e-05	0.00019	CcSEcCtD
Ropinirole—Discomfort—Irbesartan—type 2 diabetes mellitus	2.15e-05	0.00019	CcSEcCtD
Ropinirole—Skin disorder—Metformin—type 2 diabetes mellitus	2.15e-05	0.00019	CcSEcCtD
Ropinirole—Immune system disorder—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000189	CcSEcCtD
Ropinirole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	2.14e-05	0.000189	CcSEcCtD
Ropinirole—Dyspepsia—Valsartan—type 2 diabetes mellitus	2.14e-05	0.000189	CcSEcCtD
Ropinirole—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000189	CcSEcCtD
Ropinirole—Dizziness—Bromocriptine—type 2 diabetes mellitus	2.13e-05	0.000188	CcSEcCtD
Ropinirole—Dry mouth—Irbesartan—type 2 diabetes mellitus	2.13e-05	0.000188	CcSEcCtD
Ropinirole—Palpitations—Losartan—type 2 diabetes mellitus	2.13e-05	0.000188	CcSEcCtD
Ropinirole—Nausea—Glimepiride—type 2 diabetes mellitus	2.12e-05	0.000187	CcSEcCtD
Ropinirole—Arrhythmia—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000187	CcSEcCtD
Ropinirole—Loss of consciousness—Losartan—type 2 diabetes mellitus	2.12e-05	0.000187	CcSEcCtD
Ropinirole—Nausea—Sitagliptin—type 2 diabetes mellitus	2.12e-05	0.000187	CcSEcCtD
Ropinirole—Dyspepsia—Orlistat—type 2 diabetes mellitus	2.11e-05	0.000187	CcSEcCtD
Ropinirole—Asthenia—Glyburide—type 2 diabetes mellitus	2.11e-05	0.000187	CcSEcCtD
Ropinirole—Decreased appetite—Valsartan—type 2 diabetes mellitus	2.11e-05	0.000187	CcSEcCtD
Ropinirole—Anorexia—Metformin—type 2 diabetes mellitus	2.11e-05	0.000186	CcSEcCtD
Ropinirole—Cough—Losartan—type 2 diabetes mellitus	2.1e-05	0.000186	CcSEcCtD
Ropinirole—Urticaria—Gliclazide—type 2 diabetes mellitus	2.1e-05	0.000186	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.1e-05	0.000185	CcSEcCtD
Ropinirole—Alopecia—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000185	CcSEcCtD
Ropinirole—Fatigue—Valsartan—type 2 diabetes mellitus	2.1e-05	0.000185	CcSEcCtD
Ropinirole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	2.09e-05	0.000185	CcSEcCtD
Ropinirole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	2.09e-05	0.000185	CcSEcCtD
Ropinirole—Oedema—Irbesartan—type 2 diabetes mellitus	2.09e-05	0.000185	CcSEcCtD
Ropinirole—Decreased appetite—Orlistat—type 2 diabetes mellitus	2.09e-05	0.000184	CcSEcCtD
Ropinirole—Pruritus—Glyburide—type 2 diabetes mellitus	2.08e-05	0.000184	CcSEcCtD
Ropinirole—Mental disorder—Ramipril—type 2 diabetes mellitus	2.08e-05	0.000184	CcSEcCtD
Ropinirole—Constipation—Valsartan—type 2 diabetes mellitus	2.08e-05	0.000184	CcSEcCtD
Ropinirole—Infection—Irbesartan—type 2 diabetes mellitus	2.08e-05	0.000183	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.07e-05	0.000183	CcSEcCtD
Ropinirole—Fatigue—Orlistat—type 2 diabetes mellitus	2.07e-05	0.000183	CcSEcCtD
Ropinirole—Hypotension—Metformin—type 2 diabetes mellitus	2.07e-05	0.000183	CcSEcCtD
Ropinirole—Malnutrition—Ramipril—type 2 diabetes mellitus	2.07e-05	0.000182	CcSEcCtD
Ropinirole—Shock—Irbesartan—type 2 diabetes mellitus	2.06e-05	0.000182	CcSEcCtD
Ropinirole—Pain—Orlistat—type 2 diabetes mellitus	2.05e-05	0.000181	CcSEcCtD
Ropinirole—Arthralgia—Losartan—type 2 diabetes mellitus	2.05e-05	0.000181	CcSEcCtD
Ropinirole—Chest pain—Losartan—type 2 diabetes mellitus	2.05e-05	0.000181	CcSEcCtD
Ropinirole—Myalgia—Losartan—type 2 diabetes mellitus	2.05e-05	0.000181	CcSEcCtD
Ropinirole—Vomiting—Bromocriptine—type 2 diabetes mellitus	2.05e-05	0.000181	CcSEcCtD
Ropinirole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	2.05e-05	0.000181	CcSEcCtD
Ropinirole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.05e-05	0.000181	CcSEcCtD
Ropinirole—Anxiety—Losartan—type 2 diabetes mellitus	2.04e-05	0.000181	CcSEcCtD
Ropinirole—Tachycardia—Irbesartan—type 2 diabetes mellitus	2.04e-05	0.00018	CcSEcCtD
Ropinirole—Rash—Bromocriptine—type 2 diabetes mellitus	2.03e-05	0.00018	CcSEcCtD
Ropinirole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.03e-05	0.000179	CcSEcCtD
Ropinirole—Skin disorder—Irbesartan—type 2 diabetes mellitus	2.03e-05	0.000179	CcSEcCtD
Ropinirole—Tension—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000179	CcSEcCtD
Ropinirole—Discomfort—Losartan—type 2 diabetes mellitus	2.03e-05	0.000179	CcSEcCtD
Ropinirole—Dysgeusia—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000179	CcSEcCtD
Ropinirole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	2.02e-05	0.000178	CcSEcCtD
Ropinirole—Headache—Bromocriptine—type 2 diabetes mellitus	2.02e-05	0.000178	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.02e-05	0.000178	CcSEcCtD
Ropinirole—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.02e-05	0.000178	CcSEcCtD
Ropinirole—Nervousness—Ramipril—type 2 diabetes mellitus	2.01e-05	0.000177	CcSEcCtD
Ropinirole—Dry mouth—Losartan—type 2 diabetes mellitus	2.01e-05	0.000177	CcSEcCtD
Ropinirole—Anorexia—Irbesartan—type 2 diabetes mellitus	1.99e-05	0.000176	CcSEcCtD
Ropinirole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.99e-05	0.000176	CcSEcCtD
Ropinirole—Paraesthesia—Metformin—type 2 diabetes mellitus	1.99e-05	0.000176	CcSEcCtD
Ropinirole—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.99e-05	0.000175	CcSEcCtD
Ropinirole—Confusional state—Losartan—type 2 diabetes mellitus	1.98e-05	0.000175	CcSEcCtD
Ropinirole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.98e-05	0.000175	CcSEcCtD
Ropinirole—Dyspnoea—Metformin—type 2 diabetes mellitus	1.97e-05	0.000174	CcSEcCtD
Ropinirole—Somnolence—Metformin—type 2 diabetes mellitus	1.97e-05	0.000174	CcSEcCtD
Ropinirole—Oedema—Losartan—type 2 diabetes mellitus	1.97e-05	0.000174	CcSEcCtD
Ropinirole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.96e-05	0.000174	CcSEcCtD
Ropinirole—Infection—Losartan—type 2 diabetes mellitus	1.95e-05	0.000173	CcSEcCtD
Ropinirole—Hypotension—Irbesartan—type 2 diabetes mellitus	1.95e-05	0.000172	CcSEcCtD
Ropinirole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.95e-05	0.000172	CcSEcCtD
Ropinirole—Dyspepsia—Metformin—type 2 diabetes mellitus	1.95e-05	0.000172	CcSEcCtD
Ropinirole—Tremor—Ramipril—type 2 diabetes mellitus	1.94e-05	0.000171	CcSEcCtD
Ropinirole—Shock—Losartan—type 2 diabetes mellitus	1.93e-05	0.000171	CcSEcCtD
Ropinirole—Urticaria—Valsartan—type 2 diabetes mellitus	1.93e-05	0.000171	CcSEcCtD
Ropinirole—Nervous system disorder—Losartan—type 2 diabetes mellitus	1.93e-05	0.00017	CcSEcCtD
Ropinirole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.92e-05	0.00017	CcSEcCtD
Ropinirole—Decreased appetite—Metformin—type 2 diabetes mellitus	1.92e-05	0.00017	CcSEcCtD
Ropinirole—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.92e-05	0.00017	CcSEcCtD
Ropinirole—Tachycardia—Losartan—type 2 diabetes mellitus	1.92e-05	0.000169	CcSEcCtD
Ropinirole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000169	CcSEcCtD
Ropinirole—Nausea—Bromocriptine—type 2 diabetes mellitus	1.91e-05	0.000169	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.91e-05	0.000169	CcSEcCtD
Ropinirole—Fatigue—Metformin—type 2 diabetes mellitus	1.91e-05	0.000169	CcSEcCtD
Ropinirole—Urticaria—Orlistat—type 2 diabetes mellitus	1.91e-05	0.000169	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.9e-05	0.000168	CcSEcCtD
Ropinirole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.9e-05	0.000168	CcSEcCtD
Ropinirole—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.9e-05	0.000168	CcSEcCtD
Ropinirole—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.9e-05	0.000168	CcSEcCtD
Ropinirole—Asthenia—Gliclazide—type 2 diabetes mellitus	1.9e-05	0.000168	CcSEcCtD
Ropinirole—Agitation—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000168	CcSEcCtD
Ropinirole—Constipation—Metformin—type 2 diabetes mellitus	1.89e-05	0.000167	CcSEcCtD
Ropinirole—Angioedema—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000167	CcSEcCtD
Ropinirole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.88e-05	0.000166	CcSEcCtD
Ropinirole—Anorexia—Losartan—type 2 diabetes mellitus	1.87e-05	0.000166	CcSEcCtD
Ropinirole—Vomiting—Glyburide—type 2 diabetes mellitus	1.87e-05	0.000165	CcSEcCtD
Ropinirole—Pruritus—Gliclazide—type 2 diabetes mellitus	1.87e-05	0.000165	CcSEcCtD
Ropinirole—Malaise—Ramipril—type 2 diabetes mellitus	1.86e-05	0.000165	CcSEcCtD
Ropinirole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000165	CcSEcCtD
Ropinirole—Rash—Glyburide—type 2 diabetes mellitus	1.86e-05	0.000164	CcSEcCtD
Ropinirole—Somnolence—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000164	CcSEcCtD
Ropinirole—Dermatitis—Glyburide—type 2 diabetes mellitus	1.86e-05	0.000164	CcSEcCtD
Ropinirole—Vertigo—Ramipril—type 2 diabetes mellitus	1.86e-05	0.000164	CcSEcCtD
Ropinirole—Syncope—Ramipril—type 2 diabetes mellitus	1.85e-05	0.000164	CcSEcCtD
Ropinirole—Leukopenia—Ramipril—type 2 diabetes mellitus	1.85e-05	0.000163	CcSEcCtD
Ropinirole—Headache—Glyburide—type 2 diabetes mellitus	1.85e-05	0.000163	CcSEcCtD
Ropinirole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.84e-05	0.000162	CcSEcCtD
Ropinirole—Hypotension—Losartan—type 2 diabetes mellitus	1.84e-05	0.000162	CcSEcCtD
Ropinirole—Palpitations—Ramipril—type 2 diabetes mellitus	1.83e-05	0.000161	CcSEcCtD
Ropinirole—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.82e-05	0.000161	CcSEcCtD
Ropinirole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.82e-05	0.00016	CcSEcCtD
Ropinirole—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.82e-05	0.00016	CcSEcCtD
Ropinirole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.81e-05	0.00016	CcSEcCtD
Ropinirole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.81e-05	0.00016	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.8e-05	0.000159	CcSEcCtD
Ropinirole—Cough—Ramipril—type 2 diabetes mellitus	1.8e-05	0.000159	CcSEcCtD
Ropinirole—Fatigue—Irbesartan—type 2 diabetes mellitus	1.8e-05	0.000159	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.79e-05	0.000158	CcSEcCtD
Ropinirole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.79e-05	0.000158	CcSEcCtD
Ropinirole—Convulsion—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000158	CcSEcCtD
Ropinirole—Constipation—Irbesartan—type 2 diabetes mellitus	1.79e-05	0.000158	CcSEcCtD
Ropinirole—Pain—Irbesartan—type 2 diabetes mellitus	1.79e-05	0.000158	CcSEcCtD
Ropinirole—Insomnia—Losartan—type 2 diabetes mellitus	1.78e-05	0.000157	CcSEcCtD
Ropinirole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.77e-05	0.000156	CcSEcCtD
Ropinirole—Paraesthesia—Losartan—type 2 diabetes mellitus	1.77e-05	0.000156	CcSEcCtD
Ropinirole—Urticaria—Metformin—type 2 diabetes mellitus	1.76e-05	0.000155	CcSEcCtD
Ropinirole—Arthralgia—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000155	CcSEcCtD
Ropinirole—Chest pain—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000155	CcSEcCtD
Ropinirole—Myalgia—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000155	CcSEcCtD
Ropinirole—Dyspnoea—Losartan—type 2 diabetes mellitus	1.75e-05	0.000155	CcSEcCtD
Ropinirole—Anxiety—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000155	CcSEcCtD
Ropinirole—Nausea—Glyburide—type 2 diabetes mellitus	1.75e-05	0.000155	CcSEcCtD
Ropinirole—Abdominal pain—Metformin—type 2 diabetes mellitus	1.75e-05	0.000155	CcSEcCtD
Ropinirole—Dizziness—Gliclazide—type 2 diabetes mellitus	1.75e-05	0.000155	CcSEcCtD
Ropinirole—Somnolence—Losartan—type 2 diabetes mellitus	1.75e-05	0.000154	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000154	CcSEcCtD
Ropinirole—Asthenia—Valsartan—type 2 diabetes mellitus	1.74e-05	0.000154	CcSEcCtD
Ropinirole—Discomfort—Ramipril—type 2 diabetes mellitus	1.74e-05	0.000153	CcSEcCtD
Ropinirole—Dyspepsia—Losartan—type 2 diabetes mellitus	1.73e-05	0.000153	CcSEcCtD
Ropinirole—Asthenia—Orlistat—type 2 diabetes mellitus	1.72e-05	0.000152	CcSEcCtD
Ropinirole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.72e-05	0.000152	CcSEcCtD
Ropinirole—Pruritus—Valsartan—type 2 diabetes mellitus	1.72e-05	0.000152	CcSEcCtD
Ropinirole—Dry mouth—Ramipril—type 2 diabetes mellitus	1.72e-05	0.000152	CcSEcCtD
Ropinirole—Decreased appetite—Losartan—type 2 diabetes mellitus	1.71e-05	0.000151	CcSEcCtD
Ropinirole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.71e-05	0.000151	CcSEcCtD
Ropinirole—Confusional state—Ramipril—type 2 diabetes mellitus	1.7e-05	0.00015	CcSEcCtD
Ropinirole—Pruritus—Orlistat—type 2 diabetes mellitus	1.7e-05	0.00015	CcSEcCtD
Ropinirole—Fatigue—Losartan—type 2 diabetes mellitus	1.7e-05	0.00015	CcSEcCtD
Ropinirole—Oedema—Ramipril—type 2 diabetes mellitus	1.69e-05	0.000149	CcSEcCtD
Ropinirole—Vomiting—Gliclazide—type 2 diabetes mellitus	1.68e-05	0.000149	CcSEcCtD
Ropinirole—Constipation—Losartan—type 2 diabetes mellitus	1.68e-05	0.000149	CcSEcCtD
Ropinirole—Pain—Losartan—type 2 diabetes mellitus	1.68e-05	0.000149	CcSEcCtD
Ropinirole—Rash—Gliclazide—type 2 diabetes mellitus	1.67e-05	0.000147	CcSEcCtD
Ropinirole—Dermatitis—Gliclazide—type 2 diabetes mellitus	1.67e-05	0.000147	CcSEcCtD
Ropinirole—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.66e-05	0.000147	CcSEcCtD
Ropinirole—Urticaria—Irbesartan—type 2 diabetes mellitus	1.66e-05	0.000147	CcSEcCtD
Ropinirole—Shock—Ramipril—type 2 diabetes mellitus	1.66e-05	0.000147	CcSEcCtD
Ropinirole—Headache—Gliclazide—type 2 diabetes mellitus	1.66e-05	0.000146	CcSEcCtD
Ropinirole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	1.65e-05	0.000146	CcSEcCtD
Ropinirole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.65e-05	0.000146	CcSEcCtD
Ropinirole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.65e-05	0.000146	CcSEcCtD
Ropinirole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.65e-05	0.000146	CcSEcCtD
Ropinirole—Tachycardia—Ramipril—type 2 diabetes mellitus	1.65e-05	0.000145	CcSEcCtD
Ropinirole—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.64e-05	0.000145	CcSEcCtD
Ropinirole—Skin disorder—Ramipril—type 2 diabetes mellitus	1.64e-05	0.000145	CcSEcCtD
Ropinirole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000144	CcSEcCtD
Ropinirole—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.62e-05	0.000143	CcSEcCtD
Ropinirole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.61e-05	0.000142	CcSEcCtD
Ropinirole—Dizziness—Valsartan—type 2 diabetes mellitus	1.61e-05	0.000142	CcSEcCtD
Ropinirole—Anorexia—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000142	CcSEcCtD
Ropinirole—Dizziness—Orlistat—type 2 diabetes mellitus	1.59e-05	0.00014	CcSEcCtD
Ropinirole—Asthenia—Metformin—type 2 diabetes mellitus	1.59e-05	0.00014	CcSEcCtD
Ropinirole—Hypotension—Ramipril—type 2 diabetes mellitus	1.58e-05	0.000139	CcSEcCtD
Ropinirole—Nausea—Gliclazide—type 2 diabetes mellitus	1.57e-05	0.000139	CcSEcCtD
Ropinirole—Pruritus—Metformin—type 2 diabetes mellitus	1.57e-05	0.000138	CcSEcCtD
Ropinirole—Urticaria—Losartan—type 2 diabetes mellitus	1.56e-05	0.000138	CcSEcCtD
Ropinirole—Abdominal pain—Losartan—type 2 diabetes mellitus	1.55e-05	0.000137	CcSEcCtD
Ropinirole—Body temperature increased—Losartan—type 2 diabetes mellitus	1.55e-05	0.000137	CcSEcCtD
Ropinirole—Vomiting—Valsartan—type 2 diabetes mellitus	1.55e-05	0.000137	CcSEcCtD
Ropinirole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.54e-05	0.000136	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.54e-05	0.000136	CcSEcCtD
Ropinirole—Rash—Valsartan—type 2 diabetes mellitus	1.53e-05	0.000135	CcSEcCtD
Ropinirole—Dermatitis—Valsartan—type 2 diabetes mellitus	1.53e-05	0.000135	CcSEcCtD
Ropinirole—Vomiting—Orlistat—type 2 diabetes mellitus	1.53e-05	0.000135	CcSEcCtD
Ropinirole—Insomnia—Ramipril—type 2 diabetes mellitus	1.52e-05	0.000135	CcSEcCtD
Ropinirole—Headache—Valsartan—type 2 diabetes mellitus	1.52e-05	0.000135	CcSEcCtD
Ropinirole—Diarrhoea—Metformin—type 2 diabetes mellitus	1.51e-05	0.000134	CcSEcCtD
Ropinirole—Rash—Orlistat—type 2 diabetes mellitus	1.51e-05	0.000134	CcSEcCtD
Ropinirole—Paraesthesia—Ramipril—type 2 diabetes mellitus	1.51e-05	0.000134	CcSEcCtD
Ropinirole—Dermatitis—Orlistat—type 2 diabetes mellitus	1.51e-05	0.000134	CcSEcCtD
Ropinirole—Headache—Orlistat—type 2 diabetes mellitus	1.5e-05	0.000133	CcSEcCtD
Ropinirole—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000133	CcSEcCtD
Ropinirole—Asthenia—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.000132	CcSEcCtD
Ropinirole—Somnolence—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000132	CcSEcCtD
Ropinirole—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.48e-05	0.000131	CcSEcCtD
Ropinirole—Pruritus—Irbesartan—type 2 diabetes mellitus	1.48e-05	0.000131	CcSEcCtD
Ropinirole—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000129	CcSEcCtD
Ropinirole—Dizziness—Metformin—type 2 diabetes mellitus	1.46e-05	0.000129	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.46e-05	0.000129	CcSEcCtD
Ropinirole—Fatigue—Ramipril—type 2 diabetes mellitus	1.45e-05	0.000128	CcSEcCtD
Ropinirole—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.45e-05	0.000128	CcSEcCtD
Ropinirole—Nausea—Valsartan—type 2 diabetes mellitus	1.44e-05	0.000128	CcSEcCtD
Ropinirole—Constipation—Ramipril—type 2 diabetes mellitus	1.44e-05	0.000127	CcSEcCtD
Ropinirole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.43e-05	0.000126	CcSEcCtD
Ropinirole—Nausea—Orlistat—type 2 diabetes mellitus	1.43e-05	0.000126	CcSEcCtD
Ropinirole—Asthenia—Losartan—type 2 diabetes mellitus	1.41e-05	0.000125	CcSEcCtD
Ropinirole—Vomiting—Metformin—type 2 diabetes mellitus	1.41e-05	0.000124	CcSEcCtD
Ropinirole—Rash—Metformin—type 2 diabetes mellitus	1.4e-05	0.000123	CcSEcCtD
Ropinirole—Dermatitis—Metformin—type 2 diabetes mellitus	1.39e-05	0.000123	CcSEcCtD
Ropinirole—Pruritus—Losartan—type 2 diabetes mellitus	1.39e-05	0.000123	CcSEcCtD
Ropinirole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000123	CcSEcCtD
Ropinirole—Headache—Metformin—type 2 diabetes mellitus	1.39e-05	0.000122	CcSEcCtD
Ropinirole—Dizziness—Irbesartan—type 2 diabetes mellitus	1.38e-05	0.000122	CcSEcCtD
Ropinirole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.38e-05	0.000122	CcSEcCtD
Ropinirole—Diarrhoea—Losartan—type 2 diabetes mellitus	1.35e-05	0.000119	CcSEcCtD
Ropinirole—Urticaria—Ramipril—type 2 diabetes mellitus	1.34e-05	0.000118	CcSEcCtD
Ropinirole—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.33e-05	0.000118	CcSEcCtD
Ropinirole—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.33e-05	0.000118	CcSEcCtD
Ropinirole—Vomiting—Irbesartan—type 2 diabetes mellitus	1.33e-05	0.000117	CcSEcCtD
Ropinirole—Rash—Irbesartan—type 2 diabetes mellitus	1.32e-05	0.000116	CcSEcCtD
Ropinirole—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.32e-05	0.000116	CcSEcCtD
Ropinirole—Nausea—Metformin—type 2 diabetes mellitus	1.31e-05	0.000116	CcSEcCtD
Ropinirole—Headache—Irbesartan—type 2 diabetes mellitus	1.31e-05	0.000116	CcSEcCtD
Ropinirole—Dizziness—Losartan—type 2 diabetes mellitus	1.3e-05	0.000115	CcSEcCtD
Ropinirole—Vomiting—Losartan—type 2 diabetes mellitus	1.25e-05	0.00011	CcSEcCtD
Ropinirole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.24e-05	0.00011	CcSEcCtD
Ropinirole—Nausea—Irbesartan—type 2 diabetes mellitus	1.24e-05	0.00011	CcSEcCtD
Ropinirole—Rash—Losartan—type 2 diabetes mellitus	1.24e-05	0.000109	CcSEcCtD
Ropinirole—Dermatitis—Losartan—type 2 diabetes mellitus	1.24e-05	0.000109	CcSEcCtD
Ropinirole—Headache—Losartan—type 2 diabetes mellitus	1.23e-05	0.000109	CcSEcCtD
Ropinirole—Asthenia—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000107	CcSEcCtD
Ropinirole—Pruritus—Ramipril—type 2 diabetes mellitus	1.19e-05	0.000105	CcSEcCtD
Ropinirole—Nausea—Losartan—type 2 diabetes mellitus	1.17e-05	0.000103	CcSEcCtD
Ropinirole—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.15e-05	0.000102	CcSEcCtD
Ropinirole—Dizziness—Ramipril—type 2 diabetes mellitus	1.11e-05	9.85e-05	CcSEcCtD
Ropinirole—Vomiting—Ramipril—type 2 diabetes mellitus	1.07e-05	9.47e-05	CcSEcCtD
Ropinirole—Rash—Ramipril—type 2 diabetes mellitus	1.06e-05	9.39e-05	CcSEcCtD
Ropinirole—Dermatitis—Ramipril—type 2 diabetes mellitus	1.06e-05	9.38e-05	CcSEcCtD
Ropinirole—Headache—Ramipril—type 2 diabetes mellitus	1.06e-05	9.33e-05	CcSEcCtD
Ropinirole—Nausea—Ramipril—type 2 diabetes mellitus	1e-05	8.84e-05	CcSEcCtD
Ropinirole—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.33e-06	2.39e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.33e-06	2.39e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.33e-06	2.39e-05	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.32e-06	2.38e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.32e-06	2.38e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.32e-06	2.38e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.32e-06	2.37e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.31e-06	2.36e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.31e-06	2.36e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.31e-06	2.36e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.31e-06	2.35e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.3e-06	2.35e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.3e-06	2.35e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.3e-06	2.34e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.3e-06	2.34e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.3e-06	2.34e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.3e-06	2.34e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.3e-06	2.34e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.3e-06	2.33e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.29e-06	2.32e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	2.31e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.29e-06	2.31e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.28e-06	2.31e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.28e-06	2.31e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.28e-06	2.3e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.28e-06	2.3e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.27e-06	2.29e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.27e-06	2.28e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-06	2.28e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-06	2.28e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.26e-06	2.27e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.26e-06	2.27e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.26e-06	2.27e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.26e-06	2.27e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.26e-06	2.27e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.26e-06	2.26e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	2.25e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.25e-06	2.24e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.24e-06	2.24e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	2.23e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.24e-06	2.23e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.24e-06	2.23e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.23e-06	2.22e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.23e-06	2.21e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.23e-06	2.21e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	2.21e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.23e-06	2.21e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.22e-06	2.2e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.22e-06	2.2e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.22e-06	2.19e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.22e-06	2.19e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.22e-06	2.19e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.21e-06	2.17e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.2e-06	2.16e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.2e-06	2.16e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.2e-06	2.16e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.2e-06	2.15e-05	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.19e-06	2.15e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.19e-06	2.15e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.19e-06	2.14e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.18e-06	2.13e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.18e-06	2.13e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-06	2.13e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-06	2.13e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.18e-06	2.12e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.17e-06	2.11e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.17e-06	2.11e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.17e-06	2.1e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.17e-06	2.1e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.17e-06	2.1e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.16e-06	2.1e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.16e-06	2.09e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.16e-06	2.09e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.16e-06	2.09e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.16e-06	2.09e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.16e-06	2.08e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.16e-06	2.08e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.15e-06	2.08e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.15e-06	2.08e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.15e-06	2.07e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.15e-06	2.06e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.15e-06	2.06e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.14e-06	2.06e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.14e-06	2.06e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.14e-06	2.05e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.14e-06	2.05e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.14e-06	2.05e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-06	2.04e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.13e-06	2.04e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.13e-06	2.03e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.13e-06	2.03e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	2.03e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.12e-06	2.02e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.12e-06	2.01e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.12e-06	2.01e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	2e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-06	2e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.11e-06	2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.11e-06	1.99e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.11e-06	1.99e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.11e-06	1.99e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-06	1.99e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.1e-06	1.98e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.1e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.09e-06	1.97e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.09e-06	1.97e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.09e-06	1.97e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.09e-06	1.96e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-06	1.96e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.09e-06	1.95e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.09e-06	1.95e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.08e-06	1.95e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-06	1.94e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.08e-06	1.94e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.07e-06	1.93e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-06	1.92e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.06e-06	1.91e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.06e-06	1.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.06e-06	1.9e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.06e-06	1.9e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-06	1.88e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-06	1.88e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.04e-06	1.88e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.04e-06	1.88e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.04e-06	1.86e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-06	1.86e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.03e-06	1.86e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	1.84e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	1.83e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-06	1.82e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-06	1.82e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1e-06	1.81e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1e-06	1.81e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1e-06	1.8e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1e-06	1.8e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.97e-07	1.79e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.96e-07	1.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.96e-07	1.79e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.96e-07	1.79e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	9.91e-07	1.78e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.87e-07	1.78e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	9.82e-07	1.77e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.81e-07	1.77e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.7e-07	1.75e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.65e-07	1.74e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	9.63e-07	1.73e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	9.59e-07	1.72e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	9.51e-07	1.71e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.48e-07	1.71e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.43e-07	1.7e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	9.43e-07	1.7e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	9.4e-07	1.69e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	9.38e-07	1.69e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.38e-07	1.69e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.38e-07	1.69e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	9.36e-07	1.68e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.33e-07	1.68e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	9.32e-07	1.68e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	9.26e-07	1.67e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.23e-07	1.66e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.22e-07	1.66e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	9.22e-07	1.66e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.2e-07	1.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.07e-07	1.63e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.05e-07	1.63e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.04e-07	1.63e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	8.99e-07	1.62e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	8.99e-07	1.62e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.98e-07	1.62e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.92e-07	1.61e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.9e-07	1.6e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.85e-07	1.59e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.8e-07	1.58e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	8.74e-07	1.57e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.74e-07	1.57e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.73e-07	1.57e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.68e-07	1.56e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	8.66e-07	1.56e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	8.62e-07	1.55e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.61e-07	1.55e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.6e-07	1.55e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	8.58e-07	1.54e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.51e-07	1.53e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.49e-07	1.53e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.44e-07	1.52e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	8.4e-07	1.51e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.4e-07	1.51e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.38e-07	1.51e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	8.37e-07	1.51e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.3e-07	1.49e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.27e-07	1.49e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.24e-07	1.48e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.24e-07	1.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.23e-07	1.48e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	8.16e-07	1.47e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.12e-07	1.46e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	8.12e-07	1.46e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.05e-07	1.45e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.99e-07	1.44e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	7.96e-07	1.43e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.83e-07	1.41e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.81e-07	1.41e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.8e-07	1.4e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.73e-07	1.39e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.7e-07	1.38e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.69e-07	1.38e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.66e-07	1.38e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.63e-07	1.37e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.62e-07	1.37e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	7.58e-07	1.36e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	7.54e-07	1.36e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.54e-07	1.36e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	7.34e-07	1.32e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	7.3e-07	1.31e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.22e-07	1.3e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.2e-07	1.29e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.19e-07	1.29e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	7.16e-07	1.29e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.11e-07	1.28e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.1e-07	1.28e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7e-07	1.26e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.98e-07	1.26e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	6.98e-07	1.26e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.95e-07	1.25e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.86e-07	1.23e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.71e-07	1.21e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.67e-07	1.2e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.49e-07	1.17e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.41e-07	1.15e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	6.39e-07	1.15e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.27e-07	1.13e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.19e-07	1.11e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.16e-07	1.11e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.15e-07	1.11e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.99e-07	1.08e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.89e-07	1.06e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	5.82e-07	1.05e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.79e-07	1.04e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.63e-07	1.01e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.43e-07	9.78e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.39e-07	9.7e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.39e-07	9.7e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.35e-07	9.62e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.27e-07	9.49e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.93e-07	8.87e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.86e-07	8.75e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.79e-07	6.82e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.21e-07	5.78e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.48e-07	4.46e-06	CbGpPWpGaD
